[c09aa8]: / clusters / ordered9kclusters / clust_675.txt

Download this file

37 lines (36 with data), 2.7 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Normal organ and marrow function:
Patients must have normal or near normal organ function as defined by their treating institutions BMT program clinical practice guidelines.
Patients must have normal organ and marrow function as defined at the discretion of the treating physician and principal investigator (PI)
PRE-SCREENING: Must have normal organ function with liver function tests (LFTs) < 2.5 x upper limit of normal (ULN)
Normal organ and bone marrow function defined as:
Normal bone marrow and organ function as defined below:
Adequate normal organ and marrow function as defined below (must be done within 30 days prior to enrolment):
Patients must have normal organ function as defined below:
Patients must have normal organ function as defined below:
Normal organ and bone marrow function as defined by:
Acceptable organ and marrow function during the Screening Period as defined by the\n protocol.
Patients must have normal organ and bone marrow function measured within 28 days of randomisation,
Have organ and marrow function at the screening and pre-dose visits as defined by:
Patients must have normal organ and marrow function as defined below:
Patients must have normal organ and marrow function documented within 7 days of study enrollment as defined below:
Patients must have normal marrow function as defined below:
Patient must have normal bone marrow and organ function as defined below
Patients must have normal organ and marrow function as defined below:
Normal organ and bone marrow
ECOG performance status ? 1 Patients must have normal organ and marrow function as defined below:
Subjects must have normal organ and bone marrow function measured within 28 days prior to administration of study treatment;
Patients must have normal organ and marrow function as defined below:
Patients must have normal organ and marrow function as defined below:
Must have normal organ and marrow function reported within 14 days prior to randomization
The subject has poor organ and marrow function as defined in the protocol.
Subject must have normal organ and marrow function as defined below:
Patients must have normal organ and marrow function as defined below:
Patients must have normal organ and marrow function
Normal organ function tests including Creatinine
Normal organ function tests including Bilirubin
Normal organ and marrow function.
Normal organ and marrow function
Normal organ and marrow function within limits as defined below:
Patients must have normal marrow function as defined:
Subjects must have normal organ and marrow function as defined below:
Subjects must have normal organ and marrow function as defined below: